Growing evidence suggests that aberration of the DNA repair pathway significantly contributes to tumorigenesis. Singlenucleotide polymorphisms in DNA repair-related genes such as WRN have been implicated in cancer risk. However, the results of published studies remain inconclusive. Therefore, we performed a meta-analysis of all available and relevant published studies to clarify the role of this polymorphism in cancer. We performed a computerized search of PubMed for publications on WRN Cys1367Arg (T>C) polymorphism and cancer risk and analyzed the genotype data. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated to assess the association. Sensitivity analysis, heterogeneity test, cumulative meta-analysis, and bias assessment were performed using STATA software 11.0. No association was found between WRN Cys1367Arg (T>C) polymorphism and cancer risk in all genetic models. When stratified by cancer type, results showed that this polymorphism increased the risk of breast cancer (2CCþCT vs 2TTþCT: perallele OR ¼ 1.14, 95% CI ¼ 1.03-1.26, P trend ¼ .012; CC vs TT: OR ¼ 1.43, 95% CI ¼ 1.04-1.95, P value ¼ .026; CCþCT vs TT: OR ¼ 1.14, 95% CI ¼ 1.02-1.28, P value ¼ .027). In another analysis stratified by ethnicity, WRN Cys1367Arg (T>C) polymorphism was significantly associated with cancer susceptibility in Europeans (2CCþCT vs 2TTþCT: perallele OR ¼ 1.09, 95% CI ¼ 1.00-1.19, P trend ¼ .042; CT vs TT: OR ¼ 1.13, 95% CI ¼ 1.01-1.27, P value ¼ .032; and CCþCT vs TT: OR ¼ 1.13, 95% CI ¼ 1.02-1.26, P value ¼ .025). Our study suggests that WRN Cys1367Arg (T>C) polymorphism is not associated with overall cancer risk, although subgroup analyses suggested an association with breast cancer and overall cancer specifically in European populations.